Meridian Medical Technologies
Meridian Medical Technologies is a pharmaceutical company that specializes in the design and production of medical devices and emergency response products. The company is a subsidiary of Pfizer, one of the world's largest pharmaceutical companies.
History[edit]
Meridian Medical Technologies was founded in 1968. Over the years, it has developed a reputation for its innovative approach to medical technology. In 2003, it was acquired by King Pharmaceuticals, which was subsequently acquired by Pfizer in 2010.
Products[edit]
Meridian Medical Technologies is best known for its Auto-Injector products, which are used to deliver medication quickly and effectively in emergency situations. The company's flagship product is the EpiPen, an auto-injector used to treat severe allergic reactions, or anaphylaxis. Other notable products include the DuoDote auto-injector for treating nerve gas exposure, and the Cyanokit for treating cyanide poisoning.
Research and Development[edit]
Meridian Medical Technologies has a strong focus on research and development, with a commitment to improving its existing products and developing new ones. The company's R&D efforts are primarily focused on auto-injector technology and emergency response products.
Controversies[edit]
Meridian Medical Technologies has faced several controversies, particularly related to the pricing of the EpiPen. In 2016, the company was criticized for significantly increasing the price of the EpiPen, leading to accusations of price gouging.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
